What's at stake for pharma in Pelosi's pricing plan? Megabillions—but there's reason not to panic

11th September 2019 Uncategorised 0

A leaked drug pricing plan sent some pharma investors running for the exits over the past two days, even as Congressional aides said the plan was outdated and analysts called it “unpassable.” 

More: What's at stake for pharma in Pelosi's pricing plan? Megabillions—but there's reason not to panic
Source: fierce